Robert Deluccia J.'s most recent trade in Acurx Pharmaceuticals Inc was a trade of 250,000 Stock Option done . Disclosure was reported to the exchange on Feb. 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Acurx Pharmaceuticals Inc | Robert J. Deluccia | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 250,000 | 250,000 | - | - | Stock Option | |
| Acurx Pharmaceuticals Inc | Robert J. Deluccia | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.02 per share. | 06 Jan 2025 | 49,261 | 1,010,196 | - | 1.0 | 50,000 | Common Stock |
| Acurx Pharmaceuticals Inc | Robert J. Deluccia | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 06 Jan 2025 | 49,261 | 49,261 | - | - | Warrants for Common Stock | |
| Acurx Pharmaceuticals Inc | Robert J. Deluccia | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 250,000 | 250,000 | - | - | Stock Option | |
| Acurx Pharmaceuticals Inc | Deluccia Robert J. | Director, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 02 Dec 2021 | 40,000 | 1,011,198 | - | 0 | Common Stock | |
| Acurx Pharmaceuticals Inc | Robert J. Deluccia | Director, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 02 Dec 2021 | 40,000 | 971,198 | - | 0 | Common Stock | |
| Acurx Pharmaceuticals Inc | J. Robert Deluccia | Director, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 02 Dec 2021 | 30,000 | 941,198 | - | 0 | Common Stock | |
| Acurx Pharmaceuticals Inc | J. Robert Deluccia | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.55 per share. | 02 Dec 2021 | 19,737 | 960,935 | - | 3.5 | 70,066 | Common Stock |
| Acurx Pharmaceuticals Inc | Robert Deluccia J. | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2021 | 19,737 | 0 | - | - | Warrants for Common Stock | |
| Acurx Pharmaceuticals Inc | Robert J. Deluccia | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 4.90 per share. | 19 Nov 2021 | 5,034 | 1,031,461 | - | 4.9 | 24,672 | Common Stock |
| Acurx Pharmaceuticals Inc | Robert J. Deluccia | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2021 | 500,000 | 500,000 | - | - | Stock Option | |
| Acurx Pharmaceuticals Inc | Robert J. Deluccia | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2021 | 350,000 | 350,000 | - | - | Stock Option |